北美下一代抗体市场预测至 2028 年 - 按治疗领域（肿瘤学、自身免疫或炎症）和技术（抗体-药物偶联物、双特异性抗体、Fc 工程抗体、抗体片段和抗体样）进行的 COVID-19 影响和区域分析蛋白质和生物仿制药抗体产品）
No. of Pages: 132 | Report Code: TIPRE00028002 | Category: Life Sciences
No. of Pages: 132 | Report Code: TIPRE00028002 | Category: Life Sciences
市场的增长是由于癌症患病率的增加和对下一代抗体疗法的需求不断增长。然而，与下一代抗体的制造和批准相关的并发症预计将限制预测期内的市场增长。
癌症已成为主要原因全世界的死亡。根据世界卫生组织 (WHO) 的数据，2019 年，癌症是 183 个国家 70 岁以下人群的第一大死因，也是全球 123 个国家的第四大死因。 患病率不断上升癌症的发生给世界各地的医疗保健系统造成了负担。据国际癌症研究机构 (IARC) 称，到 2040 年，全球新增癌症病例负担预计将达到约 2750 万。到那一年，该疾病可能会导致约 1.63 亿人死亡。生活方式的改变、吸烟、体力活动减少以及不确定的健康和气候条件等因素预计将在未来几年增加世界一些地区癌症患者的负担。因此，控制全球癌症患者数量的增加至关重要。
各国政府已启动计划和举措，以加强癌症的预防措施和治疗。例如，2017年，世界卫生大会批准了癌症决议（WHA70.12）——预防和控制癌症的综合方法。该计划一直呼吁世界卫生组织和各国政府加紧努力，实现预防和控制非传染性疾病（NCD）全球行动计划（2013-2020）和2030年联合国议程中规定的目标。可持续发展可减少癌症早期死亡。此外，各种民间组织也加入了防止癌症负担日益增加的行动计划，从而产生了对更好的疾病预防措施的需求。因此，癌症患病率的上升加速了对新的有效治疗方法（例如下一代抗体）的需求，从而推动了市场的发展。
北美受到严重影响，因为COVID-19 大流行的爆发。美国登记的因 COVID-19 大流行而死亡的人数最高。疫情给美国、加拿大和墨西哥的医疗基础设施带来了巨大负担。大多数制药和生物技术公司以及研究机构都参与了 COVID-19 疫苗和药物的开发。
老牌制药公司和小型初创公司都已挺身而出，致力于推进针对新冠病毒的治疗方法和疫苗。由新型冠状病毒引起的感染。因此，制药和生物技术公司、研究中心和教育研究机构的疫苗相关研究活动被认为是必不可少的，并且运营和产出基本不受影响。然而，由于研究活动的增加，预计未来几年分析资金的可及性和对抗体（包括下一代抗体）的需求将会增长。
<世界各地的许多研究人员都参与了 SARS-CoV-2 的病毒检查，该病毒导致了 COVID-19。检查为疫苗和治疗药物产生的抗体，以平衡目标病毒的功能效率。
单克隆抗体服务的批准随着 COVID-19 疫苗的开发而增加。 2020年初，由于实验室暂时关闭，从事下一代抗体市场的公司的服务受到了负面影响。然而，随着封锁限制逐渐解除，世界各地的研究实验室开始重新开放。因此，大多数服务提供商优先采取行动来促进关键工作，例如提供一系列高质量的 COVID-19 相关研究工具、重新分配研发资源来生产 SARS-Cov-2 的基本产品、扩大供应链，并支持 SARS-CoV-2/COVID-19 研究所需的长期产品的增加需求。他们还重点就英国、美国和中国的 SARS-CoV-2 诊断、药物和疫苗开发进行讨论和合作。考虑到这些因素，可以说COVID-19对下一代抗体市场的影响是积极的。因此，在预测期内，COVID-19 大流行预计将有助于北美下一代抗体市场。
Strategic insights for North America Next-generation Antibody involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 2,457.09 Million |
| Market Size by 2028 | US$ 5,428.80 Million |
| Global CAGR (2021 - 2028) | 12.0% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 治疗领域
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Next-generation Antibody refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Next-generation Antibody Market is valued at US$ 2,457.09 Million in 2021, it is projected to reach US$ 5,428.80 Million by 2028.
As per our report North America Next-generation Antibody Market, the market size is valued at US$ 2,457.09 Million in 2021, projecting it to reach US$ 5,428.80 Million by 2028. This translates to a CAGR of approximately 12.0% during the forecast period.
The North America Next-generation Antibody Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Next-generation Antibody Market report:
The North America Next-generation Antibody Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Next-generation Antibody Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Next-generation Antibody Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Next-generation Antibody Market
